How should a PMHNP use a positive depression or anxiety screen?

Use it to guide a clinical interview. Establish symptom duration, impairment, context, medical and substance contributors, and safety concerns. For depression, ask about past mania or hypomania before treating the presentation as unipolar. A score helps track symptoms but cannot, by itself, establish the diagnosis or dictate treatment.

What makes a psychiatric presentation an immediate safety problem?

Assess imminent danger and possible medical instability first. Suicidal intent with a feasible plan and access to means calls for immediate protection and a higher level of evaluation. New confusion, abnormal vital signs, or fluctuating attention may indicate delirium or intoxication and warrants urgent medical assessment. Definitive psychiatric treatment follows stabilization and a fuller assessment.

How do psychotherapy and medication decisions fit together?

Match the intervention to the diagnosis, patient goals, severity, prior response, and practical access. Cognitive behavioral therapy targets patterns of thought and behavior; exposure addresses avoidance; interpersonal therapy focuses on relationship problems linked to mood. Medication choices also require a review of interactions, contraindications, adverse effects, and monitoring. Shared decisions should include reasonable alternatives.

PMHNP-BC Study Guide: Clinical Reasoning Across the Lifespan

Start with concept 1 Choose a topic

Psychiatric-mental health nurse practitioners combine psychiatric assessment with advanced nursing judgment across the lifespan. A useful way to study is to follow a clinical decision from mechanism to action: identify what may be causing a symptom, gather evidence that changes the differential, decide whether immediate safety needs come first, and select treatment with its monitoring needs in view. A positive screen starts an assessment; it does not establish a diagnosis. Likewise, a psychiatric history should not hide a new medical illness, medication effect, or substance-related condition. The concepts below use patient situations to practice those distinctions in children, adults, and older adults. They also connect psychotherapy choices, informed consent, cultural context, and professional boundaries to decisions a PMHNP may face.

Scientific Foundation

1. Stress physiology and symptom persistence

A prolonged threat or caregiving burden can keep the sympathetic nervous system and hypothalamic-pituitary-adrenal axis active. Increased arousal makes it harder to fall asleep; fragmented sleep then weakens attention, emotion regulation, and tolerance of ordinary stress. The result can resemble anxiety or depression even when the original demand is understandable. Ask when symptoms began, whether they track the stressor, what sleep was like beforehand, and how work, relationships, and daily care have changed. Also assess safety, substance use, and medical contributors. A stressor explains a possible pathway, but it does not establish a diagnosis. The ANCC PMHNP content outline includes neurophysiology and advanced assessment; clinical reasoning still requires a patient-specific chronology and degree of impairment.

Worked example: After four months caring for a parent, an adult sleeps poorly, startles at phone calls, and loses focus at work. Persistent arousal and short sleep could account for all three changes. The PMHNP asks whether symptoms began with caregiving, persist during respite, and impair functioning, while assessing mood, anxiety, substances, and safety. Those answers distinguish an expected stress response from a disorder requiring a fuller diagnostic formulation.

Watch the distinction: Treating caregiving stress as the diagnosis skips the symptom pattern and impairment. A clear stressor can coexist with major depression, an anxiety disorder, or a medical problem.

Reference: [1]

2. Brain circuits behind psychiatric symptoms

Threat learning links a cue with danger through networks involving the amygdala, hippocampus, and prefrontal cortex. The amygdala helps detect salience, the hippocampus supplies context, and prefrontal networks help update a response when the situation is safe. Repeated avoidance prevents corrective learning, so a person may intellectually recognize safety yet still feel intense fear. Reward circuitry also matters: relief after escape can reinforce avoidance, while reduced response to ordinary rewards may accompany low motivation. None of these symptoms can be assigned to one damaged brain region in an individual patient. Ask what happened before the fear began, which cues trigger it, whether fear occurs unexpectedly, and how avoidance affects life. That pattern helps distinguish trauma-related fear, a specific phobia, panic-related avoidance, and other explanations.

Worked example: A patient knows an elevator has been inspected but feels intense fear near its doors and takes the stairs. A prior frightening ride may have linked the elevator with danger; taking the stairs produces immediate relief and strengthens avoidance. The PMHNP asks about that history, unexpected panic attacks, other feared settings, and functional loss before deciding which diagnosis best fits.

Watch the distinction: Saying the patient lacks insight because fear persists despite recognizing safety confuses reasoning with a learned threat response. Insight alone does not extinguish avoidance.

Reference: [1]

3. Dopamine pathways and drug effects

Dopamine receptor blockade can produce different outcomes because dopamine pathways serve different functions. Reduced mesolimbic signaling can lessen hallucinations and delusions. Blockade in the nigrostriatal pathway can disrupt movement control, causing parkinsonian stiffness, slowed movement, or other extrapyramidal symptoms. Dopamine normally restrains prolactin release through the tuberoinfundibular pathway, so blockade there can raise prolactin and cause menstrual changes, sexual dysfunction, or breast symptoms. These effects vary by drug, dose, and individual susceptibility; receptor action does not prove every symptom is drug caused. Establish the timing of treatment and symptoms, examine movement, review other medicines and medical causes, and assess clinically relevant prolactin effects. Treatment benefit and adverse effects belong in the same decision about continuation or change.

Worked example: Two weeks after starting an antipsychotic, a patient reports fewer voices but new stiffness and missed menstrual periods. Mesolimbic blockade plausibly explains the benefit, nigrostriatal blockade the stiffness, and tuberoinfundibular blockade the menstrual change. The PMHNP documents a focused movement examination, checks pregnancy and other relevant causes, evaluates prolactin-related symptoms, and reviews the medication plan.

Watch the distinction: Calling stiffness and menstrual change evidence that psychosis is worsening overlooks distinct drug effects. Improvement in hallucinations does not establish that the treatment is tolerable or safe.

Reference: [1]

4. Serotonin signaling and treatment latency

A selective serotonin reuptake inhibitor blocks the serotonin transporter soon after a dose, increasing serotonin availability at synapses. Mood improvement usually takes longer because downstream receptor responses, network activity, and behavior change over time. Early adverse effects can appear before benefit, so ask about tolerability, adherence, sleep, agitation, and safety rather than declaring failure after a few days. Additional serotonergic drugs or supplements can increase the risk of serotonin toxicity. Concerning findings include new agitation or confusion with autonomic changes and neuromuscular signs such as tremor, hyperreflexia, or clonus, especially after an addition or dose change. Review the exact product and all prescribed and nonprescribed substances before combining them. A suspected toxic syndrome needs urgent assessment, not routine reassurance about expected treatment latency.

Worked example: After five days of an SSRI, a patient reports no mood improvement and proposes adding St. John's wort. The short interval does not establish treatment failure: transporter blockade precedes clinical response. The PMHNP identifies the supplement as a potential serotonergic interaction, advises against adding it without a medication review, assesses current adverse effects and suicide risk, and arranges appropriate follow-up.

Watch the distinction: Immediate transporter blockade does not mean immediate antidepressant benefit. Adding a serotonergic supplement to speed improvement may add toxicity risk without resolving the reason for the delayed response.

Reference: [1]

5. GABA, glutamate, and neural excitation

GABA is a principal inhibitory transmitter, while glutamate supplies much of the brain's excitatory signaling. Medicines that enhance GABA-mediated inhibition can reduce anxiety or produce sedation. With regular exposure, neural systems adapt to that inhibitory influence. Abrupt removal may leave excitation temporarily unopposed, producing tremor, anxiety, insomnia, autonomic arousal, and sometimes seizures. The risk depends on the substance, pattern of use, co-exposures, and medical condition, so the word sedative is not enough to predict severity. Determine exactly what was taken, how often, when it stopped, and whether there is confusion, marked autonomic instability, or a seizure history. Assess immediate medical stability before planning longer-term treatment for anxiety or substance use. The mechanism explains why withdrawal symptoms can differ sharply from ordinary recurrence of the original anxiety.

Worked example: A patient who took a sedative every day stops suddenly and develops shaking, sweating, and pronounced agitation. Adaptation to enhanced inhibition makes rebound excitation plausible. The PMHNP checks vital signs, attention, substance history, timing of the last dose, and seizure risk, and arranges urgent medical assessment when complicated withdrawal is possible. Simply restarting an anxiety interview would miss the immediate safety issue.

Watch the distinction: Attributing new tremor solely to the patient's baseline anxiety ignores the timing of sedative cessation. Withdrawal can progress to dangerous neurologic or autonomic complications.

Reference: [1]

6. Pharmacokinetic interactions

Pharmacokinetics describes what the body does to a drug: absorption brings it into circulation, metabolism transforms it, and elimination removes it. A metabolic inhibitor can reduce clearance of a substrate drug, increasing exposure even though the prescribed dose and receptor action are unchanged. An inducer may have the opposite effect, although onset and offset can lag behind the medication change. Renal function, liver function, formulation, adherence, and timing can alter the interpretation. Pharmacodynamics instead concerns effects at receptors or other targets, including additive sedation without a change in blood concentration. When adverse effects appear after a new medicine, construct a medication timeline and identify a plausible interaction before attributing the change to psychiatric illness. Monitoring or dose adjustment must follow the specific drug's properties and the patient's clinical state.

Worked example: A patient has been stable on a psychiatric medicine for months. Days after another prescriber adds a known inhibitor of its metabolic pathway, the patient becomes unusually sedated. Reduced clearance can raise exposure without any change to the original prescription. The PMHNP checks the exact agents, doses, timing, other sedatives, and medical status, then coordinates a safe medication review.

Watch the distinction: A fixed prescription dose does not guarantee a fixed drug exposure. Assuming a new symptom proves relapse overlooks changes in metabolism, elimination, or interacting substances.

Reference: [1]

7. Organ function and medication exposure

Drug exposure depends partly on organ function. Reduced kidney clearance can increase concentrations of renally eliminated medicines, while liver disease or enzyme interactions can alter metabolism of many other agents. Lithium deserves particular attention because kidney handling of lithium is linked to sodium and fluid balance. Dehydration can reduce clearance and increase toxicity risk even when the prescribed dose has not changed. Worsening tremor, unsteadiness, vomiting, or confusion should prompt assessment of toxicity and alternative causes. Review fluid loss, new drugs, renal function, and the timing of the last dose; obtain a properly timed lithium concentration when indicated and interpret it with symptoms and kidney findings. An older adult's lower physiologic reserve may make a modest exposure change clinically important.

Worked example: An older adult taking lithium has two days of vomiting, then develops coarse tremor and an unsteady gait. Fluid loss may have increased lithium exposure. The PMHNP arranges prompt clinical evaluation, reviews recent medicines and intake, and obtains indicated kidney tests and a timed lithium level. Treating the vomiting-related fluid loss is part of the response; an isolated level would not explain the whole presentation.

Watch the distinction: A previously stable lithium dose is not proof of current safety. Dehydration, kidney changes, and interacting medicines can raise exposure while the prescription remains identical.

Reference: [1]

8. Receptor profiles and adverse effects

A medicine's receptor profile often predicts a cluster of adverse effects better than its therapeutic label does. Muscarinic blockade reduces secretions and gut motility, contributing to dry mouth, constipation, urinary difficulty, and sometimes cognitive problems. Histamine H1 blockade commonly contributes to sedation and appetite change. Alpha-1 adrenergic blockade can impair the usual vascular response to standing, causing dizziness or a blood pressure drop. Several effects can occur together when one drug acts at multiple receptors. Ask when symptoms began, examine hydration and bowel function, review other anticholinergic or sedating drugs, and assess orthostatic symptoms and falls. This is especially consequential for older adults, whose medication burden and lower reserve can amplify harm. Treatment decisions weigh symptom benefit against the patient's actual adverse effects and risks.

Worked example: After a medication change, a patient develops dry mouth, constipation, morning grogginess, and dizziness on standing. Muscarinic blockade could explain the first two, H1 blockade the grogginess, and alpha-1 blockade the standing dizziness. The PMHNP reviews the full regimen, checks fall history and relevant vital signs, and discusses whether a safer adjustment preserves the treatment benefit.

Watch the distinction: Grouping all four complaints as generic sedation misses constipation and standing dizziness as separate receptor effects. Each may require a different assessment and change the safety decision.

Reference: [1]

9. Movement and toxic syndromes

Timing and associated signs separate several antipsychotic-related syndromes. Akathisia is a distressing inner restlessness with a need to move; acute dystonia causes sustained, often painful muscle contractions. Parkinsonism produces stiffness, slowed movement, or tremor. Tardive dyskinesia usually involves repetitive involuntary movements after longer exposure, although timing alone is imperfect. Neuroleptic malignant syndrome is a medical emergency suggested by severe rigidity, fever, altered consciousness, and autonomic instability after dopamine blockade. Serotonin toxicity follows serotonergic exposure and more often features hyperreflexia or clonus, agitation, and autonomic findings. Examine the patient and review recent medication changes rather than labeling every movement an extrapyramidal effect. Severe systemic illness calls for immediate emergency care while definitive diagnosis and treatment proceed.

Worked example: A patient taking an antipsychotic develops marked rigidity, fever, confusion, and unstable vital signs. This combination raises concern for neuroleptic malignant syndrome, beyond ordinary medication-related stiffness. The PMHNP initiates emergency medical evaluation, communicates the antipsychotic exposure and symptom timeline, and ensures the suspected offending medicine is reviewed urgently. Waiting for a routine movement rating visit would be unsafe.

Watch the distinction: Calling fever and altered consciousness routine parkinsonism ignores systemic toxicity. Conversely, restlessness without fever is not automatically neuroleptic malignant syndrome; the complete pattern matters.

Reference: [1]

10. Heritability and pharmacogenomics

Family history changes the probability of some psychiatric disorders but cannot establish that an individual has one. It should sharpen questions about episodes, sleep, energy, impairment, and independent symptom history. Pharmacogenomic results answer a different question. A reported enzyme phenotype may predict slower or faster metabolism of particular medicines that use that pathway, changing possible exposure at a given dose. Its value depends on whether the drug actually relies on that enzyme, other medicines, organ function, and the patient's observed response. A gene result does not diagnose bipolar disorder, prove that a medication will work, or replace an interaction review. Ask for the actual report rather than relying on a broad label such as slow metabolizer. Use genetic information as one input to drug selection or monitoring, alongside clinical evidence and patient preferences.

Worked example: A patient with a parent who has bipolar disorder brings a report describing slow metabolism through one enzyme. The PMHNP asks about past elevated mood, reduced need for sleep, and impairment because family history raises diagnostic vigilance. For medication planning, the PMHNP checks which specific enzyme and drug the report concerns. Neither finding establishes bipolar disorder or guarantees a preferred medicine.

Watch the distinction: Treating inherited risk as destiny confuses probability with diagnosis. Treating a metabolism result as a universal medication ranking ignores drug pathways, interactions, and actual clinical response.

Reference: [1]

11. Neurodevelopment across childhood

Developmental assessment asks what a child can do now and how those abilities changed over time. A child who has always had limited reciprocal interaction or communication may show a longstanding developmental difference. Loss of previously reliable words, social engagement, or other acquired skills is regression and raises a different concern, including possible neurologic, hearing, or other medical causes. Obtain concrete examples and a timeline from caregivers, teachers, and records where available. Consider language exposure, hearing, cognitive level, trauma, and opportunities for social interaction before interpreting behavior. Observe play, response to name, nonverbal communication, and shared attention in a developmentally appropriate way. The PMHNP can evaluate psychiatric and developmental patterns while coordinating indicated medical assessment for regression. A symptom checklist without developmental history can obscure this distinction.

Worked example: One preschooler has rarely used gestures to share interests and has consistently struggled with back-and-forth play. Another spoke in short sentences six months ago but now uses few words. The first history suggests a longstanding developmental pattern; the second documents lost ability. The PMHNP verifies each timeline and arranges assessment of the second child's language regression and possible medical contributors.

Watch the distinction: Calling both children simply language delayed erases the difference between never acquiring a skill and losing it. Regression warrants a focused search for causes.

Reference: [1]

12. Aging, cognition, and drug sensitivity

Later-life symptoms can change with reduced physiologic reserve, altered drug clearance, sensory impairment, and a larger medication burden. Sedating and anticholinergic medicines may cause disproportionate confusion, impaired balance, constipation, or falls in a frail person. Acute confusion requires attention to onset and fluctuation: delirium may reflect infection, dehydration, medication effects, metabolic disturbance, or several contributors together. A preexisting neurocognitive disorder increases vulnerability but does not explain every abrupt change. Compare current attention and function with the patient's baseline, obtain collateral history, review recent prescriptions and nonprescription products, and examine for acute illness. Coordinate urgent medical evaluation when delirium is possible. The related psychiatric mental health nursing guide can reinforce general nursing observations; PMHNP assessment also requires differential diagnosis and treatment decisions.

Worked example: A frail older adult who usually manages conversation becomes confused and falls twice after a sedating medicine is added. The timing makes medication contribution plausible, while infection, dehydration, and injury remain possible. The PMHNP checks attention and vital signs, reviews all recent medicines, obtains baseline information from family, and arranges timely assessment of acute causes before labeling this dementia progression.

Watch the distinction: An older patient's memory diagnosis does not make sudden confusion expected. Abrupt change with falls demands evaluation for delirium, medication effects, and other treatable causes.

Reference: [1]

13. Focused physical assessment

Physical findings can change the psychiatric differential. Panic-like episodes may include palpitations and tremor, but endocrine disease, arrhythmia, stimulant exposure, and other medical conditions can produce similar sensations. Establish whether symptoms come in discrete surges or remain present between episodes, and ask about medications, caffeine, substances, heat intolerance, weight change, and family history. Check vital signs and perform a focused cardiovascular, thyroid, and neurologic examination. Choose tests to answer the leading questions, such as thyroid assessment for a compatible symptom cluster or cardiac evaluation when the history suggests an arrhythmia. A positive medical finding still requires interpretation: it may explain the symptoms, coexist with anxiety, or be unrelated. The PMHNP's goal is a defensible differential and safe coordination of care, not a diagnosis from one symptom.

Worked example: A patient reports new episodes of racing heart, but also has ongoing weight loss, heat intolerance, and a fine tremor between episodes. Those persistent findings make an endocrine cause plausible. The PMHNP checks pulse and other vital signs, examines the thyroid and cardiovascular system, reviews substances, and arranges appropriate thyroid testing and medical evaluation before diagnosing primary panic disorder.

Watch the distinction: Palpitations plus fear do not prove panic disorder. Symptoms outside the attacks, especially weight loss and persistent tremor, should redirect the assessment toward medical causes.

Reference: [1]

Advanced Practice Skills

14. Opening a clinical interview

A broad opening question lets the patient define the immediate concern before the clinician narrows the interview. Reflection checks understanding and can reveal what matters most to the patient. Then build a chronology: baseline function, first change, progression, triggers, prior episodes, and effects on sleep, work, relationships, and daily care. Focused questions test competing explanations, including mood episodes, substance effects, medical illness, and safety. A phrase such as “I cannot cope” deserves direct inquiry about self-harm, but it does not by itself establish suicidal intent. Use clear language and a calm, nonjudgmental manner; asking directly about suicide is compatible with empathic interviewing. Summarize the account and check corrections before forming a differential. The sequence turns an ambiguous complaint into evidence while protecting against both premature reassurance and premature diagnosis.

Worked example: A patient begins, “I cannot cope anymore.” The PMHNP asks, “What has become hardest recently?” and reflects the answer. Follow-up establishes that sleep and work changed after a separation three weeks ago. The PMHNP asks directly about thoughts of suicide, intent, plan, and access to means. The initial statement now has context, and safety is assessed without assuming its meaning.

Watch the distinction: Starting with a diagnosis checklist alone can miss the patient's chronology. Avoiding a direct safety question because the opening sounds vague can miss serious risk.

Reference: [1]

15. Motivational interviewing

Motivational interviewing treats ambivalence as information about competing values, not defiance. Open questions, reflections, affirmations, and summaries help patients hear their own reasons for change. The clinician listens for change talk, such as a wish for better sleep, and sustain talk, such as fear of losing a familiar evening routine. Asking permission before offering information protects collaboration. A useful next step is specific and chosen by the patient; it need not be immediate abstinence. Explore confidence, obstacles, and what the patient already knows about the behavior's effects. In a PMHNP visit, this method complements assessment of substance-related harm and withdrawal risk rather than replacing them. Arguing that the patient must change often increases resistance and obscures the person's actual readiness and safety needs.

Worked example: An adult says evening alcohol helps them relax but they want more restorative sleep. The PMHNP reflects both aims and asks what sleep feels like after drinking compared with alcohol-free evenings. The patient notices more nighttime waking after drinking and chooses to record drinking and sleep for a week. The next visit can use those observations to discuss a patient-selected change.

Watch the distinction: Lecturing about alcohol before exploring ambivalence may win agreement in the room without changing behavior. A collaboratively chosen observation or step provides usable evidence and ownership.

Reference: [1]

16. Depression and anxiety screening

The PHQ-9 and GAD-7 organize reports of depressive and anxiety symptoms and can track change over time. They are screening and symptom measures, not substitutes for a diagnostic interview. Interpret responses alongside chronology, impairment, medical conditions, substances, and the patient's own account. A depressive screen should prompt questions about prior elevated or irritable mood, increased energy, decreased need for sleep, impulsive behavior, and consequences, because bipolar illness can present during a depressive phase. Any indication of self-harm requires direct assessment of thoughts, intent, plan, access, and immediate safety. Scores also need context when language, literacy, or a medical symptom affects responses. PMHNP-BC practice questions can help rehearse this distinction: a positive screen identifies what to investigate, while the history establishes the clinical formulation.

Worked example: A patient endorses frequent depressive symptoms on the PHQ-9, then recalls a distinct period of little sleep without fatigue, unusually high energy, and impulsive spending. The screen supports current symptom burden but cannot classify the lifetime mood disorder. The PMHNP establishes the episode's duration, impairment, substances, and collateral evidence, and assesses safety before selecting a treatment approach.

Watch the distinction: A high depressive symptom score is not proof of unipolar depression. Ignoring a past elevated-energy episode can lead to a treatment decision based on an incomplete diagnosis.

Reference: [1]

17. Multi-informant ADHD assessment

ADHD assessment asks whether attention or activity symptoms are persistent, impairing, developmentally inappropriate, and evident across more than one setting. Parent and teacher reports provide different views of the same child; disagreement is a reason to investigate context, not automatically to average their answers. Vanderbilt forms can structure observations, but ratings alone do not establish diagnosis. Compare classroom demands with home tasks, and ask about sleep, learning difficulty, hearing or vision problems, trauma, anxiety, and mood. Determine when symptoms began and whether school performance, relationships, or daily routines are affected. A child who struggles only during reading may need a learning evaluation; a child who is inattentive after poor sleep may have a different primary problem. Combine reports, developmental history, observation, and focused examination before deciding on care.

Worked example: A teacher reports frequent inattention, while a parent sees few problems at home. The PMHNP reviews both Vanderbilt forms, asks which subjects and times are hardest, and learns that difficulties cluster during reading lessons. Sleep is adequate, and the child completes other tasks. A learning assessment and closer review of classroom demands are warranted before concluding that ADHD explains the discrepancy.

Watch the distinction: One positive teacher form is not a complete ADHD diagnosis. Differences between settings may reveal task-specific learning difficulty, stress, sleep problems, or missing observations.

Reference: [1]

18. Mental status examination

The mental status examination separates what the patient reports from what the clinician observes during a particular encounter. Mood is the patient's described emotional state; affect is the observed range, intensity, and fit of emotional expression. Speech rate and amount, psychomotor activity, thought process, thought content, perception, orientation, attention, and insight provide additional evidence. Rapid speech and frequent shifts between topics may suggest an activated mood state, but substance use, anxiety, medication effects, and baseline communication style remain alternatives. Record concrete observations rather than inferring a diagnosis from a single sign. Clarify whether ideas connect logically, whether unusual beliefs are fixed, and whether the patient is sleeping less without fatigue. The examination is a snapshot, so compare it with longitudinal history and collateral information when possible.

Worked example: A patient says, “I feel fine,” while speaking rapidly, changing topics repeatedly, and showing expansive affect. The PMHNP records the reported mood as “fine” and documents the observed speech, thought process, and affect separately. Questions about sleep, energy, impulsive behavior, substances, and functional change determine whether these findings reflect a mood episode or another cause.

Watch the distinction: Writing “euphoric mood” solely because affect appears expansive replaces the patient's report with an observation. Keeping the two separate makes the diagnostic reasoning clearer.

Reference: [1]

19. Attention and fluctuating cognition

Delirium is suggested by an acute change in attention and awareness that fluctuates, often with altered orientation or thinking. Inattention can appear as losing the thread of a conversation, failing to follow simple instructions, or being unable to sustain a brief task. Dementia generally follows a more gradual course, although a person with dementia can also develop delirium. Ask family or staff for the last known baseline and the timing of change. Review medication additions, infection symptoms, dehydration, pain, substance exposure or withdrawal, and other medical causes. Check vital signs and immediate safety while arranging urgent medical assessment. A calm or briefly lucid interval does not exclude delirium because symptoms can vary across the day. The PMHNP should communicate the abrupt change clearly rather than attributing it to age or psychiatric history.

Worked example: An older inpatient who conversed clearly yesterday becomes disoriented overnight and repeatedly loses track of questions. The abrupt onset and impaired attention favor possible delirium. The PMHNP checks vital signs and recent medications, obtains the family's baseline account, and requests urgent medical evaluation for causes such as infection or metabolic disturbance. A new dementia diagnosis would not account for the overnight change.

Watch the distinction: Orientation alone is an incomplete cognitive assessment. A patient may answer some orientation questions yet have fluctuating attention that signals an acute medical problem.

Reference: [1]

20. Suicide risk formulation

Suicide risk formulation combines current thoughts, intent, plan, access to means, timing, prior behavior, acute stressors, substance use, and protective factors. Ask direct, specific questions and distinguish a passive wish to be dead from intent to act. A detailed plan with immediate access and stated intent signals a need for immediate protective evaluation. Protective factors matter, but they do not cancel imminent danger; assess whether the patient can use supports and participate reliably in a safety plan. Review changes in risk over time and document the evidence and actions taken. The intervention should match the immediacy of risk, including emergency services or a higher level of care when needed, within the PMHNP's setting and applicable law. A questionnaire item can prompt assessment but cannot replace this individualized judgment.

Worked example: A patient says they intend to die tonight, names a specific method, and has immediate access to it. They also say they love their family. The intent, plan, timing, and access make urgent protective evaluation the priority. The PMHNP maintains safety, arranges emergency assessment through the available pathway, communicates the relevant risk facts, and does not rely on the family connection alone.

Watch the distinction: A protective relationship does not erase stated intent and immediate access. Treating a positive screen as the entire risk assessment also misses plan, timing, and capacity for safety planning.

Reference: [1]

21. Violence risk assessment

A threat becomes more concerning when it identifies a person, describes a feasible act, names a near-term time, and is paired with access to means. Ask what the patient intends to do, what preparations have occurred, and what might stop them. Assess agitation, intoxication, prior violence, recent losses, and the intended person's proximity. A protective relationship matters, but it does not cancel a specific, actionable plan. Formulation should distinguish angry speech from imminent danger while remaining alert to uncertainty and rapidly changing circumstances. The PMHNP should arrange immediate safety measures and emergency evaluation when indicated, document the patient's statements and clinical reasoning, and follow the jurisdiction's rules on protective disclosure. The ANCC PMHNP test content outline includes risk assessment and psychiatric emergency management.

Worked example: An adult says a named coworker will be harmed after today's shift and describes where a weapon is stored. The patient is agitated and has been drinking. The named target, same-day plan, access, and intoxication make the risk urgent. Maintain safety, arrange emergency assessment, obtain appropriate consultation, and carry out applicable protective duties. Explore history and protective factors without delaying these steps.

Watch the distinction: Treating a threat as harmless because the patient also expresses remorse overlooks access and timing. Reassess intent and take immediate protective action when the plan is feasible.

Reference: [1]

22. Agitation and immediate stabilization

Agitation is a behavior requiring a safety assessment, not a diagnosis. Start with a calm approach, enough space, a clear exit, reduced stimulation, and simple choices. Assess vital signs, awareness, orientation, glucose when clinically appropriate, recent substances or medication changes, and signs of injury or infection. Disorientation, sweating, abnormal vital signs, or fluctuating attention suggest a medical or toxic process that needs urgent evaluation. Verbal de-escalation and voluntary treatment are preferred when feasible; medication or physical restriction may be necessary if danger persists, with monitoring and local safeguards. Reassess frequently because the cause and level of risk can change. A patient whose agitation results from hypoxia or hypoglycemia needs correction of that condition, even if a psychiatric history makes a behavioral explanation seem familiar.

Worked example: A 46-year-old patient is pacing, sweating, and shouting. The pulse is 132 beats/minute, and the patient cannot state where they are. Staff clear nearby hazards and speak briefly from a safe distance while emergency medical assessment begins. Glucose, oxygenation, exposure history, and other causes are assessed. Labeling this primary psychosis would miss potentially reversible medical danger.

Watch the distinction: Giving a sedative and ending the assessment may quiet behavior while concealing a medical emergency. Stabilization includes finding and treating the cause and monitoring the response.

Reference: [1]

23. Intoxication, overdose, and withdrawal

In suspected intoxication or overdose, assess airway, breathing, circulation, level of consciousness, and immediate exposure history before conducting a detailed psychiatric interview. Opioids can suppress respiratory drive, producing slow or absent breathing; oxygenation and ventilation therefore take priority over determining why the drug was used. Emergency response, respiratory support, and an opioid reversal agent when available and appropriate are time-sensitive. Reversal can wear off before an opioid's effects do, so continued observation and reassessment matter. Other drugs or medical conditions may also explain impaired consciousness. Withdrawal can be dangerous through seizures, severe autonomic disturbance, dehydration, or confusion, depending on the substance. Once medically stable, evaluate intent, co-exposures, substance-use pattern, and options for ongoing treatment. A positive toxicology result supports exposure but does not establish when, how much, or whether it caused every symptom.

Worked example: A 32-year-old is difficult to wake after a suspected opioid exposure and breathes six times per minute. The immediate problem is inadequate ventilation. Activate emergency care, support breathing, give reversal treatment according to the setting, and monitor for recurrent respiratory depression. A substance-use interview and assessment of possible self-harm follow once the patient can participate safely.

Watch the distinction: Waiting for a drug screen before supporting breathing reverses the clinical priority. Respiratory compromise is treated from the patient's condition, while tests help clarify exposure later.

Reference: [1]

24. Alcohol and drug screening tools

The Alcohol Use Disorders Identification Test (AUDIT) asks about drinking patterns and alcohol-related problems. The Drug Abuse Screening Test (DAST) addresses problems linked to drug use. These tools organize an initial conversation and can reveal use that a broad question misses. Their results are screening evidence, not a diagnosis or a measure of withdrawal severity. Follow up by asking about amount and frequency, impaired control, craving, consequences, hazardous use, attempts to cut down, and any withdrawal symptoms. Clarify which substances were used, whether prescriptions were taken as directed, and whether immediate safety concerns exist. Interpret answers in context, including the patient's understanding of the questions and willingness to disclose. PMHNP-BC practice questions can help you practice choosing the next assessment step after a positive screen.

Worked example: A 38-year-old has an elevated AUDIT result but denies previous withdrawal. The result warrants a fuller alcohol history, including weekly pattern, loss of control, missed work, injuries, and efforts to reduce use. No withdrawal history lowers concern about that particular complication but does not rule out alcohol-related harm or establish whether diagnostic criteria are met.

Watch the distinction: Converting a positive screening score directly into a substance-use-disorder diagnosis skips the required clinical history. It also mistakes risk detection for assessment of severity and consequences.

Reference: [1]

25. Withdrawal severity instruments

CIWA-Ar tracks selected symptoms of alcohol withdrawal, such as tremor, sweating, agitation, and perceptual disturbance. COWS tracks observable and reported signs of opioid withdrawal, including pulse, sweating, restlessness, pupil size, and gastrointestinal symptoms. Use the instrument matched to the suspected substance, then interpret serial findings alongside timing of last use, vital signs, examination, and comorbid illness. Scores can be misleading when a patient cannot report symptoms reliably or another illness produces the same signs. Fever, new confusion, seizure, or unstable physiology requires medical assessment even when withdrawal is plausible. A scale supports monitoring and treatment decisions within a clinical protocol; it cannot establish the cause of delirium or exclude infection, intoxication, or another emergency. Document the trend and the accompanying examination rather than a number alone.

Worked example: A hospitalized adult with recent heavy drinking develops tremor, fever, and fluctuating attention. Alcohol withdrawal is possible, so CIWA-Ar may aid monitoring if the patient can participate. Fever and confusion also raise concern for infection or another acute process. Arrange urgent medical evaluation, check vital signs and relevant investigations, and reassess withdrawal and competing causes together.

Watch the distinction: Applying COWS to suspected alcohol withdrawal, or trusting any withdrawal score despite delirium, can misdirect care. Match the tool to the substance and investigate findings it cannot explain.

Reference: [1]

26. Metabolic health promotion

Psychiatric treatment affects physical health, and cardiometabolic illness can influence medication choice. Before starting a drug with potential metabolic effects, record relevant weight history, blood pressure, glucose status, lipid information, activity, diet, and family or personal cardiovascular risk. Use these findings as a baseline for later comparison, then monitor according to the medication and the patient's risks. A change in weight alone does not identify its cause: appetite, activity, sleep, illness, and other drugs may contribute. Discuss benefits and burdens with the patient so an effective psychiatric treatment is not abandoned without a workable alternative. Health promotion should be specific and attainable. Ask about food access, safe places to move, finances, and follow-up barriers, then adapt goals and support instead of assuming that standard lifestyle advice is equally feasible for everyone.

Worked example: A 52-year-old with psychosis and hypertension is starting an antipsychotic with metabolic risk. The patient relies on a food pantry and has no safe evening walking route. Record baseline blood pressure, weight, and relevant glucose and lipid findings; plan follow-up. Together choose feasible food and activity steps and review whether the medicine's benefits continue to justify its risks.

Watch the distinction: Calling metabolic monitoring a primary-care problem misses a treatment effect the PMHNP must recognize. Equally, weight gain alone should not trigger an unplanned stop of effective treatment.

Reference: [1]

27. Psychoeducation that changes decisions

Psychoeducation works when it improves a real decision. First learn what the patient believes, what outcome matters to them, and what information is missing. Explain the likely purpose of treatment, expected course, common adverse effects, warning signs, and reasonable alternatives in plain language. Distinguish a predictable effect from dependence, toxicity, or a new illness by assessing timing and severity rather than offering reassurance from the drug name alone. Use a method the patient can use, such as a short written plan, interpreter, or demonstration. Ask the patient to explain the agreed next step in their own words; this checks whether the explanation was clear, not whether the patient was obedient. Respect a decision to decline after an informed discussion, and arrange follow-up when uncertainty or adverse effects could change the choice.

Worked example: After three days of a new antidepressant, a patient stops it because mild nausea seems to mean addiction. The PMHNP asks about timing, severity, hydration, and other symptoms, then explains that nausea can be an early adverse effect and reviews choices for managing or changing treatment. The patient restates when to seek help and which option they prefer.

Watch the distinction: Repeating a medication leaflet without checking the patient's specific fear may leave the wrong belief intact. Education should connect the symptom to the decision the patient faces.

Reference: [1]

28. Recovery and resilience planning

Recovery planning starts with what the patient wants life to include, such as work, relationships, or independent living. Symptoms and safety still matter, but progress can also be measured by participation in valued roles. Identify strengths already in use, supportive people, early warning signs, and barriers that might disrupt the plan. Translate a broad goal into manageable actions with a time and a way to review them. A relapse plan should describe whom the patient will contact, what changes signal a need for help, and which steps have worked before. Resilience is supported by practical resources and repeated opportunities to regain agency; it is not a demand that the patient remain positive. The PMHNP collaborates with the patient and, with permission, other supports while adjusting treatment to changing function and risk.

Worked example: A 29-year-old with recurring mood episodes wants part-time work. Together, they identify reliable morning routines and a supportive sibling. The first step is to explore two suitable roles this week; later steps include a limited schedule and symptom review. Less sleep and rising energy are warning signs that prompt an earlier clinical contact, not automatic abandonment of the work goal.

Watch the distinction: Defining recovery only as symptom disappearance can postpone meaningful participation indefinitely. A plan should protect safety while helping the patient take realistic steps toward chosen roles.

Reference: [1]

29. Sleep assessment as clinical evidence

Ask how much a patient sleeps, when sleep occurs, whether they try to sleep, and how they feel during the day. Insomnia usually involves difficulty sleeping despite opportunity, with fatigue or distress. A circadian problem involves a sleep schedule out of step with obligations, while total sleep may improve when the person follows their preferred schedule. Reduced need for sleep is different: the person sleeps little yet feels rested or unusually energized, raising concern for mania or hypomania when paired with other episode features. Substances, shift work, pain, breathing problems, and medications may also disrupt sleep. Establish onset, duration, baseline pattern, and effects on function. Sleep history is diagnostic evidence, but it cannot establish a mood disorder by itself; evaluate mood, activity, speech, judgment, and substance exposure together.

Worked example: A 22-year-old reports sleeping three hours nightly for several nights yet feels rested, talks rapidly, begins multiple projects, and spends impulsively. This is more concerning for a possible elevated mood episode than ordinary insomnia. Ask about episode duration, change from baseline, impairment, substances, and safety. A tired patient wishing to sleep would suggest a different sleep mechanism.

Watch the distinction: Equating every short night with insomnia misses reduced need for sleep. The patient's energy, desire for sleep, associated behavior, and change from baseline determine what the pattern suggests.

Reference: [1]

30. Safeguarding and trauma-informed assessment

Safeguarding assessment combines safety, careful information gathering, and respect for the patient's control where possible. Explain what can remain private and which concerns may require disclosure under applicable law. When safe, speak with the young person alone, use developmentally appropriate open questions, and avoid suggesting an answer. Ask about the injury's sequence and timing, current safety, and whether the patient fears going home. Document observations and the patient's words accurately, separating what was seen from what was inferred. Inconsistent accounts can arise for many reasons, including fear, coercion, memory limits, or ordinary misunderstanding; they justify further assessment, not an accusation. Evaluate immediate medical needs and follow applicable reporting and consultation pathways. A trauma-informed approach offers choices about pacing and support without promising secrecy that the clinician cannot keep.

Worked example: A 15-year-old has bruising at different stages of healing. An accompanying adult answers every question, while the adolescent changes the account of a recent injury. The PMHNP arranges a private conversation, explains confidentiality limits, asks open questions about what happened and current safety, and assesses medical needs. Findings and statements are documented, then safeguarding duties are followed.

Watch the distinction: Pressing for a disclosure in front of a possibly controlling adult may increase danger or distort the account. Private assessment and open questions provide better evidence and safer choices.

Reference: [1]

Diagnosis and Treatment

31. Unipolar depression versus bipolar illness

A current depressive presentation does not establish unipolar depression until past elevated or irritable mood episodes have been explored. Ask about distinct changes in energy, need for sleep, speech, activity, confidence, judgment, and consequences, plus what others observed. Clarify chronology, episode duration, impairment, hospitalization, and whether substances or medications could explain the change. Depression, bipolar illness, substance effects, and medical illness can overlap in reported symptoms. A history of sustained elevated energy with markedly reduced need for sleep and risky behavior changes both the differential and the treatment discussion. Antidepressant selection requires attention to possible mood switching and the patient's full episode history. Screening forms can flag symptoms but cannot substitute for this longitudinal interview. The related nurse practitioner study guide offers another route to practice clinical differentiation.

Worked example: A 35-year-old seeks help for low mood. During the history, they recall a distinct period of little sleep without fatigue, unusually high energy, rapid speech, and spending that caused serious debt. Ask when it occurred, how long it lasted, what others saw, and whether substances were involved. Investigate bipolar illness before treating the case as uncomplicated unipolar depression.

Watch the distinction: Assuming a patient is unipolar because they currently appear depressed ignores prior mood elevation. The decisive evidence may be a past episode the patient does not initially volunteer.

Reference: [1]

32. Anxiety presentations and panic

Anxiety diagnoses differ in what triggers fear and how it unfolds. Generalized anxiety involves persistent worry across several areas of life. Panic attacks are abrupt surges of intense fear or discomfort; the later worry about another attack and behavior change help explain a panic-related presentation. A specific phobia centers on a particular object or situation, while avoidance of places where escape or help feels difficult needs its own assessment. Symptoms such as palpitations, breathlessness, and tremor also occur with medical illness, stimulants, and medication effects. Ask about onset, recurrence, triggers, anticipatory fear, avoidance, functional effect, and exposure history. Focused physical assessment and testing are chosen from the history and examination, especially when symptoms are new or atypical. Avoidance can maintain fear by preventing corrective learning, which helps guide treatment formulation.

Worked example: A 41-year-old has brief episodes of intense fear with racing heart and breathlessness, then stops taking buses for fear of another episode. Ask whether attacks also occur unexpectedly, what the patient fears on the bus, and how avoidance affects work. Review caffeine, stimulant use, cardiac symptoms, and relevant examination findings before deciding how panic and avoidance fit together.

Watch the distinction: Calling any palpitations 'panic disorder' skips the attack pattern, subsequent behavior, and possible medical causes. A panic attack is a symptom pattern; diagnosis needs more context.

Reference: [1]

33. Trauma-related diagnosis

Trauma-related assessment begins by establishing the nature of the event and the patient's exposure to it. Then ask about intrusive memories or dreams, avoidance, changes in beliefs or mood, heightened arousal, and effects on daily life. Map when symptoms started and how they evolved; the same nightmares have different diagnostic meaning shortly after an event than after a sustained course. Symptoms may also reflect depression, substance use, injury, sleep disturbance, or another condition. Ask without forcing a detailed retelling, and assess immediate safety, dissociation, and supports. Diagnosis depends on the complete pattern and chronology, not on exposure alone or one striking symptom. The PMHNP can use the formulation to choose a suitable trauma-focused approach while respecting readiness, preference, and medical or safety needs that may require attention first.

Worked example: A 27-year-old survived a serious assault ten days ago and now has nightmares, avoids the street where it happened, and misses work. The event and symptoms support a trauma-related assessment, but the short timeline and incomplete symptom inventory prevent assuming a longer-lasting diagnosis. Clarify intrusion, avoidance, mood, arousal, function, and prior symptoms, then plan supportive care and reassessment.

Watch the distinction: Diagnosing a chronic trauma disorder from a recent event and nightmares alone ignores chronology and the broader symptom pattern. Exposure warrants assessment; it does not settle the diagnosis.

Reference: [1]

34. Psychosis and its differentials

Hallucinations and disorganized behavior can arise from primary psychosis, mood episodes, substances, medication effects, neurologic disease, or delirium. Determine onset and progression, level of consciousness, attention, vital signs, recent drug changes, and whether psychotic symptoms occur only during mood episodes. Fluctuating attention or abrupt confusion points toward an acute medical process even when hallucinations are prominent. A sustained pattern with clear consciousness may support a primary psychiatric condition, but requires longitudinal history and exclusion of plausible mimics. Assess immediate safety and ability to care for basic needs while investigating. Targeted examination and tests follow the clinical findings; no single laboratory result diagnoses a primary psychotic disorder. The treatment sequence may require urgent management of a toxic or infectious cause before longer-term psychiatric classification becomes reliable.

Worked example: A 68-year-old becomes disorganized and sees insects two days after a medication change. Attention varies across the interview, and the family describes a sharp departure from baseline. This pattern raises concern for delirium or a drug effect. Assess vital signs, medications, infection and metabolic clues, and immediate safety. A primary psychotic diagnosis should wait for the acute causes to be evaluated.

Watch the distinction: Focusing on the vivid hallucination while overlooking fluctuating attention can misclassify delirium as schizophrenia. Course and awareness often carry more diagnostic weight than symptom content alone.

Reference: [1]

35. ADHD across the lifespan

ADHD is a developmental pattern of inattention and/or hyperactivity and impulsivity associated with impairment, not a label for any concentration complaint. Ask how long the pattern has existed, what was evident in childhood, and whether difficulties occur in more than one setting. Seek collateral information when available and appropriate, such as school reports or a family account. Explore the specific tasks affected and the consequences, not just a symptom checklist total. Sleep deprivation, anxiety, trauma, depression, substance use, learning disorders, and medical conditions can produce similar complaints or coexist with ADHD. A recent onset after another clear problem should prompt assessment of that cause. Adult responsibilities may expose longstanding difficulties that were previously compensated for, so the absence of an earlier diagnosis does not itself rule ADHD out.

Worked example: A 30-year-old reports poor focus after six weeks of fragmented sleep during night shifts. They recall no earlier academic or home difficulties and say concentration was previously reliable. Assess the sleep schedule, mood, substances, and functional changes before considering ADHD. If later collateral history reveals longstanding impairment across settings, reassess the developmental explanation rather than relying on the recent complaint alone.

Watch the distinction: Treating a high symptom score as proof of ADHD overlooks onset, cross-setting impairment, and mimics. A checklist guides questions; the longitudinal clinical history supports diagnosis.

Reference: [1]

36. Neurocognitive disorder and delirium

A neurocognitive disorder commonly involves decline that develops over time and affects independence. Delirium is an acute disturbance with impaired attention or awareness and a course that often fluctuates. A person can have both: underlying cognitive impairment reduces reserve and may increase vulnerability to delirium during infection, dehydration, or medication change. Establish the best recent baseline from family or records, then compare onset, daily variation, attention, alertness, and physical findings. New inability to follow a conversation should trigger assessment for a reversible acute cause, even if memory problems are already documented. Evaluate immediate medical safety, medication burden, hydration, and relevant infection or metabolic clues. Cognitive testing during delirium may not represent the person's stable abilities, so reassess after the acute condition improves before revising the long-term cognitive diagnosis.

Worked example: A 79-year-old with gradual memory decline becomes unable to track conversation the day after developing fever and urinary symptoms. Family says attention was steady yesterday. The abrupt, fluctuating change suggests possible delirium superimposed on prior impairment. Arrange urgent medical evaluation, review drugs and hydration, and assess infection and other acute causes. Revisit baseline cognition after the illness resolves.

Watch the distinction: Attributing every new confusion episode to dementia progression can delay treatment of delirium. Baseline impairment explains vulnerability, but abrupt inattention demands a search for an acute cause.

Reference: [1]

37. Substance-induced symptoms and treatment

To assess whether symptoms are substance-induced, build a timeline of use, intoxication, withdrawal, symptom onset, and periods without the substance. Ask whether the same symptoms appeared before exposure or persisted independently during sustained abstinence. Collateral history can help when recall is limited, and testing may document recent exposure without proving causation. Stimulants can produce suspiciousness and agitation; withdrawal or other drugs can produce mood, sleep, or perceptual changes. Evaluate acute safety and medical complications first. Then assess the substance-use pattern, motivation for change, withdrawal risk, supports, and evidence-based treatment options suited to the substance and patient. Co-occurring primary illness remains possible, so follow symptoms over time rather than assigning a permanent diagnosis from one intoxicated encounter. Psychiatric and substance-use care should be coordinated rather than treated as separate problems.

Worked example: A 26-year-old describes paranoia during repeated stimulant binges, with no similar symptoms during a prior sustained abstinent period. The timing supports a possible substance-induced presentation, though it does not prove one. Assess agitation, sleep, cardiovascular symptoms, and immediate risk; obtain collateral history where possible. Plan follow-up through abstinence and offer substance-use treatment while reassessing for independent psychosis.

Watch the distinction: A positive drug test does not prove that every psychiatric symptom was caused by the drug. Conversely, ignoring the exposure timeline can lead to an unsupported primary diagnosis.

Reference: [1]

38. Eating disorders and medical risk

Eating-disorder assessment separates restrictive intake, binge episodes, compensatory behaviors, and body-image concerns while examining nutritional and medical consequences. A binge involves perceived loss of control, not simply eating more than intended. Purging can cause dehydration and electrolyte disturbance; weakness, fainting, palpitations, or chest symptoms raise concern for urgent medical evaluation. Ask about frequency and timing of behaviors, weight change, exercise, laxatives or diuretics, menstrual or other endocrine changes when relevant, and co-occurring mood or suicide risk. Examine hydration, vital signs, and cardiovascular findings, and select laboratory and cardiac tests according to presentation. Body size alone does not establish stability or exclude serious complications. Treatment planning integrates medical monitoring, nutrition support, psychotherapy, and the patient's readiness, with level of care determined by current risk and ability to participate.

Worked example: A 20-year-old reports recurrent episodes of eating with loss of control followed by self-induced vomiting. Today they feel weak and have palpitations. Assess vital signs, hydration, cardiac symptoms, and relevant electrolytes and cardiac findings promptly. Then clarify the behavior pattern, body-image concerns, and other compensatory actions. The urgent medical assessment does not depend on whether a final eating-disorder diagnosis has been assigned.

Watch the distinction: Waiting for a formal eating-disorder label before evaluating palpitations after purging risks missing a dangerous complication. Medical stability and diagnostic classification are related but separate decisions.

Reference: [1]

39. Selecting diagnostic tests

Choose a diagnostic test because it can answer a specific question or establish treatment safety. Start with the history and examination: fatigue, slowed thinking, cold intolerance, and depressive symptoms raise a thyroid differential, while medication exposure may suggest a different laboratory need. A thyroid result must be interpreted with its reference range, clinical pattern, and possible confounders; an isolated abnormal value does not explain every symptom automatically. Similarly, a normal result narrows one hypothesis without proving a psychiatric diagnosis. Before ordering, ask how a positive, negative, or indeterminate result would change the plan. Document that reasoning and follow up unexpected findings. This approach helps the PMHNP distinguish a medical contributor from a primary psychiatric syndrome and recognize when both need treatment. Tests supplement the interview, physical assessment, and longitudinal course.

Worked example: A 44-year-old reports two months of low mood, fatigue, slowed thinking, constipation, and cold intolerance. These findings justify thyroid evaluation alongside psychiatric assessment. If the laboratory result is abnormal, compare it with the reference range and clinical picture, evaluate the medical condition, and continue assessing mood symptoms and function. The result may identify a contributor without establishing that all depression symptoms have one cause.

Watch the distinction: Ordering a broad panel without a clinical question can generate distracting findings. Conversely, calling this depression solely psychiatric ignores physical clues that should shape targeted testing.

Reference: [1]

40. Antidepressant selection and monitoring

Antidepressant choice combines likely benefit with the patient's history, other medicines, adverse-effect risks, preferences, and ability to follow up. Before selection, assess for past mania or hypomania, substance effects, suicidality, and medical contributors to the current depression. Review all prescribed, nonprescribed, and herbal products for interactions. Serotonergic antidepressants may increase bleeding risk, especially with another medicine that affects hemostasis, so the patient's bleeding history and alternatives matter. Discuss expected treatment course, common adverse effects, warning symptoms, and a plan for early review; symptom improvement is not immediate for many agents. Monitoring should include mood, function, adherence, adverse effects, and possible activation or emerging elevated mood. A concerning bipolar history calls for a fuller diagnostic formulation before treatment is framed as unipolar depression alone.

Worked example: A 37-year-old with depression takes an anticoagulant and recalls a period of little sleep, high energy, and impulsive spending. First clarify that episode and any substance exposure, then review bleeding history, the anticoagulant, and possible antidepressant interactions. Discuss treatment choices and follow-up after the differential is clearer. Starting a serotonergic antidepressant without addressing either issue would create avoidable uncertainty and risk.

Watch the distinction: Selecting an antidepressant from the current depression score alone ignores episode history and interactions. Monitor the whole patient, including bleeding concerns and signs of mood elevation.

Reference: [1]

41. Mood stabilizers and laboratory safety

Lithium is cleared by the kidneys, so dehydration, reduced kidney function, or a new medicine that reduces lithium clearance can raise exposure without any change in the prescribed dose. Worsening tremor, vomiting, unsteadiness, or confusion should prompt assessment for toxicity. Interpret a lithium concentration alongside symptoms, kidney function, fluid status, the time of the last dose, and the time the sample was drawn. Thyroid function also matters during ongoing treatment because lithium can contribute to hypothyroidism. Anticonvulsant mood stabilizers have different safety concerns: valproate calls for attention to liver function, blood counts, and reproductive risks; lamotrigine requires careful attention to a new rash. Choose monitoring for the specific drug and patient rather than treating all mood stabilizers as interchangeable.

Worked example: A 52-year-old taking lithium starts a medicine known to reduce its kidney clearance. Four days later, their usual mild tremor worsens and they stumble while walking. The PMHNP treats possible toxicity as urgent, arranges clinical evaluation, and obtains a properly timed lithium level and kidney assessment. The new medicine and recent fluid intake are reviewed; the symptoms cannot be dismissed because the lithium dose stayed constant.

Watch the distinction: A therapeutic-looking lithium result does not settle the case if sampling time is unclear or neurologic symptoms are progressing. Clinical findings and kidney function still require prompt attention.

Reference: [1]

42. Antipsychotic selection and monitoring

Select an antipsychotic by matching its likely benefit to the patient's symptom burden and vulnerabilities. Dopamine blockade may reduce psychotic symptoms, but it can also cause movement effects and, for some drugs, prolactin-related problems. Other receptor effects contribute to sedation and orthostatic symptoms. Metabolic effects vary by agent and can matter greatly for a patient with diabetes; cardiac risk and interacting medicines may also influence selection. Record baseline concerns, then follow symptoms, functioning, adherence, weight and metabolic measures, movement findings, and any drug-specific concerns. If adverse effects emerge, weigh their severity against clinical benefit and discuss a planned adjustment or alternative. A case from PMHNP-BC practice questions is most useful when you can explain both the symptom target and the monitoring choice.

Worked example: A 38-year-old with diabetes has far fewer hallucinations after starting an antipsychotic, but gains substantial weight over several months. The PMHNP checks weight trend, glucose-related findings, diet and activity barriers, and whether psychosis remains controlled. They discuss the tradeoff and an alternative regimen or other risk reduction with follow-up. Abruptly stopping an effective drug could invite relapse without resolving the metabolic problem.

Watch the distinction: Weight gain does not prove every antipsychotic is unsuitable. Ignoring it is equally unsound: assess metabolic change, patient priorities, and relapse risk before altering treatment.

Reference: [1]

43. Somatic and complementary treatments

Electroconvulsive therapy, or ECT, produces a controlled seizure under anesthesia and may be considered when severe illness creates urgent danger or when other treatments have failed or are unsuitable. It can be relevant to severe depression with inability to eat, catatonia, or some severe mood and psychotic presentations. Evaluation includes the psychiatric indication, medical and anesthesia considerations, consent and decision-making capacity, and a plan for follow-up treatment. Memory and other adverse effects should be discussed rather than presenting ECT as a simple rescue. Complementary products need a different appraisal: ask what the patient takes, why, at what dose, and alongside which prescriptions. Evidence of benefit, product variability, adverse effects, and interactions all matter. Patient preference informs a shared decision but does not establish that a product is safe or effective.

Worked example: A 67-year-old with severe depression has stopped eating and drinking enough to remain safe and is becoming medically unwell. The PMHNP arranges urgent medical and psychiatric evaluation, including consideration of ECT because waiting for a routine medication trial may be unsafe. Capacity, consent, anesthesia assessment, and ongoing treatment are addressed. A relative's proposed herbal product does not replace stabilization or evidence-based treatment.

Watch the distinction: Considering ECT does not mean bypassing consent or medical assessment. Nor does a patient's interest in a natural product establish its safety alongside prescribed psychotropic medicines.

Reference: [1]

Psychotherapy and Related Theories

44. Cognitive behavioral therapy

Cognitive behavioral therapy links a situation, an automatic thought, emotion, bodily response, and action. The thought is treated as a testable interpretation, not as a fact to be contradicted by reassurance. Avoidance often prevents the patient from discovering whether a feared prediction is accurate, so treatment combines examination of evidence with a behavioral experiment. Define a specific prediction before the experiment, choose a manageable action, and compare the observed outcome with that prediction afterward. This approach is collaborative: the patient supplies the meaning and chooses a feasible test. In PMHNP care, the formulation sits alongside assessment of symptoms, safety, and treatment effects. The clinical mental health counseling examination guide also addresses psychotherapy concepts, though clinical decisions here remain within the PMHNP role.

Worked example: A 29-year-old employee thinks, “One mistake means I will lose my job,” and avoids asking for feedback. They predict that one question will make their supervisor threaten dismissal. Together, clinician and patient plan one brief feedback request and record the response. The supervisor instead identifies a correctable error and offers help. This weakens the absolute prediction without claiming future job security is guaranteed.

Watch the distinction: Telling the patient to think positively skips the mechanism. A useful CBT exercise identifies the precise prediction, tests it safely, and examines the actual result.

Reference: [1]

45. Dialectical behavior therapy

Dialectical behavior therapy combines acceptance with change. Validation names the understandable emotion without endorsing harmful behavior. A behavior chain then traces vulnerability factors, prompting event, thoughts, bodily cues, urges, action, and consequences. This shows where a different response can be inserted. Distress tolerance skills help the person survive a crisis without making it worse; emotion regulation addresses patterns that make intense emotion more likely; interpersonal effectiveness supports asking for needs or setting limits. Following self-harm, immediate medical needs and suicide risk take priority before skills coaching. The clinician should distinguish the short-term relief produced by self-harm from its longer-term costs, because that relief can reinforce the behavior. Practice a specific replacement response and plan how the patient will access support when urges return.

Worked example: After an argument, a 24-year-old cuts their arm and says the act briefly stopped unbearable tension. The PMHNP assesses wound care and suicide risk first. In a chain review, criticism led to shame, an urge to escape, cutting, then relief. The patient rehearses a distress tolerance skill and drafts a direct request for a pause during future arguments, with a plan for renewed risk.

Watch the distinction: Validation does not mean approving self-harm. It acknowledges the emotion while targeting the behavior and its reinforcing consequences, after immediate safety has been assessed.

Reference: [1]

46. Interpersonal therapy

Interpersonal therapy treats depressive symptoms in the context of current relationships and life events. Its common focus areas include grief, role transitions, interpersonal disputes, and persistent difficulties forming or maintaining relationships. The clinician identifies one central area, connects changes in mood to interpersonal events, and practices concrete communication or problem-solving skills. A role transition can create both loss and new demands: someone becoming a caregiver may lose social contact while struggling to request help. Exploring expectations, feelings, and available support can reveal a tractable next step. Interpersonal therapy is not simply an invitation to discuss relationships without direction. The PMHNP also evaluates severity, safety, medical contributors, and whether medication or other treatment is needed. Track whether improved communication and support are accompanied by improved functioning and mood.

Worked example: A 45-year-old becomes the main caregiver for a parent and stops seeing friends. Depressive symptoms intensify as they feel guilty asking siblings for help. The PMHNP frames caregiving as a role transition, identifies the lost contact and unmet support need, then rehearses a specific request to a sibling for one evening of coverage. Mood and social activity are reviewed at follow-up.

Watch the distinction: A role transition is a treatment focus, not proof that relationships alone caused depression. Assess the full syndrome and risk while working on the interpersonal problem.

Reference: [1]

47. Exposure and behavioral learning

Avoidance quickly lowers fear, which rewards escape and prevents new learning about a feared situation. Planned exposure reverses that loop by helping the patient encounter a safe, feared cue long enough to observe what happens without relying on habitual avoidance. The sequence should be collaborative, gradual enough to be tolerable, and tied to a clear prediction rather than a demand to feel calm immediately. Repeated experiences can teach that fear rises and changes, and that a catastrophic prediction may not occur. Exposure can be practiced in real settings or, when appropriate, through carefully designed imagery. Assess medical concerns and the actual safety of the situation first. Track approach behavior, feared outcomes, and functioning, since reduced avoidance may precede a major drop in subjective anxiety.

Worked example: A 31-year-old avoids elevators after one panic attack and predicts, “If the doors close, I will faint.” After assessing relevant medical concerns, the patient agrees to stand near an elevator, then enter with doors open, then take a short ride with support. They record anxiety and whether fainting occurred at each step. Anxiety rises during the ride, but the predicted fainting does not occur.

Watch the distinction: Exposure is not forcing a patient into the hardest situation. A tolerable, agreed sequence tests a prediction while limiting escape and other behaviors that conceal the result.

Reference: [1]

48. Humanistic practice and the alliance

A therapeutic alliance involves shared goals, agreement about the work, and a relationship in which the patient feels understood. Humanistic practice emphasizes accurate empathy, respect, and the patient's capacity to make meaning and choices. Reflection should convey the person's experience without pretending the clinician knows it better than they do. Clear boundaries support trust by making roles, confidentiality limits, and availability predictable. When a patient says the clinician dismissed a belief or cultural explanation, that rupture deserves direct attention. Acknowledge the impact, ask what was missed, and check the patient's preferred language for the experience. Then connect the corrected understanding to an actual care decision. Repair is observable when the patient can disagree, clarify goals, and continue participating; a quick apology alone may not restore collaboration.

Worked example: A 40-year-old says the clinician called their spiritual account of distress “irrational” and now hesitates to return. The PMHNP acknowledges that the comment felt dismissive, asks how the patient understands the experience, and explores its distress and functional effect. They agree to use the patient's language while continuing a careful symptom assessment. The next visit checks whether the revised approach feels workable.

Watch the distinction: Empathy does not require accepting every interpretation as a diagnosis or abandoning assessment. It requires understanding the patient's meaning before making a shared, clinically defensible plan.

Reference: [1]

49. Models of change

The Transtheoretical Model describes readiness for an individual behavior change. In contemplation, a person recognizes a possible problem but remains ambivalent; useful work explores the perceived benefits and costs of change and strengthens the person's own reasons for acting. A fixed action plan may be premature. Lewin's model addresses a different unit of change: a group or process. Unfreezing makes the need for change visible and reduces barriers, changing introduces a new practice, and refreezing embeds it in ordinary workflow. These models should guide questions and actions, not serve as labels that replace observation. For an individual, ask what they have tried and what next step they would choose. For a clinic, identify the handoff, staffing, reminders, and feedback needed for a process to persist.

Worked example: A 22-year-old thinks cannabis may worsen concentration but has made no attempt to reduce use. The PMHNP explores advantages, concerns, and the patient's own reason to experiment with change. Separately, a clinic finds missed follow-up calls: staff first map the failed handoff, then pilot a shared task list, then assign ownership and review completion. Those steps illustrate unfreezing, changing, and sustaining the process.

Watch the distinction: Contemplation is not resistance to be argued away. Lewin's stages concern a change process, so applying them as if they diagnose a patient's motivation confuses the models.

Reference: [1]

50. Developmental and family theories

Developmental, structural family, and narrative theories ask different questions about the same conflict. In adolescence, forming an identity and gaining appropriate independence are central tasks, so a wish to speak privately can be developmentally meaningful. Structural family therapy examines boundaries and interaction patterns: when a parent routinely answers for an adolescent, the pattern may restrict the young person's voice, even if the parent intends to help. Narrative work separates the person from the problem, allowing the family to examine how “the conflict” operates instead of defining the adolescent as difficult. None of these theories proves a diagnosis. The PMHNP still assesses safety, symptoms, consent, and the family's context. Therapeutic questions can invite each account, observe who speaks for whom, and identify moments when the family has handled disagreement differently.

Worked example: A 16-year-old asks to discuss school stress, but a parent answers every question. The PMHNP explains the plan for private and joint conversation, including confidentiality limits. Alone, the teen describes wanting more choice; together, both describe when “the conflict” takes over. The clinician notes the speaking boundary, asks each person for one workable change, and assesses symptoms independently.

Watch the distinction: Calling the adolescent oppositional from this interaction would mistake a family pattern for a diagnosis. Developmental needs, boundaries, and each person's account require separate assessment.

Reference: [1]

Ethics, Legal Principles, and Cultural Care

51. Informed consent and capacity

Decision-making capacity is specific to a decision and can change with time or clinical state. Assess whether the patient can communicate a choice, understand relevant information, appreciate how it applies personally, and reason among options. Disagreement with the clinician is not evidence of incapacity. Informed consent also requires a clear discussion of expected benefits, material risks, alternatives, and the likely consequence of declining treatment, presented in a way the patient can understand. Ask the patient to explain the choice in their own words rather than relying on a signed form alone. If attention, intoxication, psychosis, or cognitive impairment raises concern, examine the particular ability affected and whether support or treatment improves it. Emergency and surrogate pathways depend on applicable law and the clinical facts.

Worked example: A 36-year-old with depression declines an antidepressant. They explain the likely benefit, a feared adverse effect, psychotherapy as an alternative, and the possibility that symptoms may persist. They consistently choose psychotherapy and follow-up. The PMHNP documents the discussion and respects the decision. The choice differs from the recommendation, but the described abilities support capacity for this decision.

Watch the distinction: A psychiatric diagnosis or refusal of medication does not by itself remove capacity. Assess the person's actual understanding, appreciation, reasoning, and ability to express a choice.

Reference: [1]

52. Confidentiality and releases

Confidentiality protects clinical information, while a release defines what a patient has authorized another person to receive. Check the recipient, type of information, purpose, and any limits before sharing. Permission to coordinate appointments does not automatically permit disclosure of diagnoses, medicines, or psychotherapy content. When family members offer information, the clinician may listen without confirming protected facts; what can be shared back remains a separate question. Specific legal exceptions may permit or require disclosure in circumstances such as an immediate safety threat or mandatory reporting, but their scope depends on jurisdiction and the facts. Use the minimum information needed for the authorized or required purpose, explain relevant limits to the patient, and document what was disclosed and why. This preserves useful family involvement while respecting the patient's control over ordinary disclosures.

Worked example: A patient's sister calls to ask for the diagnosis and medication list. The record authorizes the sister only to receive appointment times. The PMHNP confirms scheduling information within that release but does not provide clinical details. They ask the patient whether they want broader involvement and document any new authorization. The sister may share her observations, which the clinician can consider without confirming the patient's treatment.

Watch the distinction: Being a close relative is not a general release of confidential information. Check the patient's authorization and any applicable exception before disclosing clinical details.

Reference: [1]

53. Threats, protection, and disclosure

A threat assessment asks what the patient intends to do, whom they may target, when, how, and whether they have access to means. History of violence, current agitation, substance effects, psychosis, and factors that may interrupt action help form the immediate risk picture. A credible, imminent threat calls for protective action while the PMHNP determines applicable emergency and disclosure duties. Those duties vary by jurisdiction, so the clinician should use the local legal pathway and seek timely consultation without delaying urgent safety measures. Document the patient's words, assessment, consultations, action taken, and rationale. Confidentiality remains important, but it is not an instruction to ignore foreseeable harm. Any disclosure should serve the protective purpose and stay within the applicable authority.

Worked example: A 33-year-old says they will attack a named coworker this afternoon and reports access to a weapon. The PMHNP immediately addresses safety, assesses intent and means, and arranges emergency evaluation. They follow the jurisdiction's protective notification requirements and document whom they contacted and why. A routine future appointment would leave the identified, time-sensitive risk unaddressed.

Watch the distinction: Treating every angry statement as identical misses specificity and imminence. Treating a detailed, feasible threat as confidential routine speech can leave a preventable danger unaddressed.

Reference: [1]

54. Involuntary care and least restriction

Clinical concern and legal authority for involuntary intervention are separate judgments. Assess the patient's immediate danger, ability to meet essential needs, mental state, available support, and willingness to accept care. Then determine whether the jurisdiction's legal criteria and process for emergency or involuntary evaluation apply. The least restrictive safe option may be voluntary urgent assessment with support when the patient can participate. More restrictive action can be justified when imminent danger and refusal make that inadequate, but the clinician must use the applicable legal pathway, required documentation, and reassessment. A diagnosis alone does not authorize detention, and a patient's refusal alone does not establish legal criteria. The PMHNP should explain what is happening as clearly as circumstances allow and preserve the patient's dignity throughout.

Worked example: Two adults describe suicidal thoughts. One agrees to immediate supervised evaluation and can participate in a safe transfer; the PMHNP arranges that voluntary route. The other describes imminent action, refuses evaluation, and attempts to leave with access to the means. The PMHNP initiates the applicable emergency process and documents the risk and why a less restrictive option was insufficient.

Watch the distinction: Involuntary care is not a default response to diagnosis or disagreement. The relevant legal criteria, immediate risk, and feasibility of a safer voluntary option all matter.

Reference: [1]

55. Children, assent, and guardians

Care for a minor involves the young person's developing ability to understand choices, the guardian's legal role, and rules that vary by jurisdiction and service. Assent means inviting the child or adolescent to participate meaningfully even when a guardian supplies formal consent. Explain confidentiality in age-appropriate terms before asking sensitive questions, including circumstances in which information may need to be shared for safety or under law. A private portion of the visit can improve disclosure about substance use, relationships, or harm while preserving appropriate guardian involvement. Avoid promising secrecy that cannot be maintained. Assess the adolescent's understanding, immediate risk, and preferences for involving supportive adults. The PMHNP documents the consent basis, what was explained, and any disclosure decision under the governing rules.

Worked example: A 15-year-old asks to discuss alcohol use without a parent present. The PMHNP explains that privacy has legal and safety limits, then offers a private conversation within those limits. The adolescent reports drinking at parties but no current intoxication or immediate danger. The clinician assesses pattern and consequences, discusses safer next steps, and determines what guardian involvement is required or useful under applicable law.

Watch the distinction: Guardian involvement does not eliminate the adolescent's voice. Promising absolute confidentiality is also unsafe when specific reporting or immediate protection duties may apply.

Reference: [1]

56. Cultural formulation

A cultural formulation asks how the patient names the problem, what they believe causes it, which supports they trust, and how family or community expectations shape help seeking. The clinician should explore meaning and function before assigning a symptom label. Hearing or sensing a deceased relative during mourning may have different significance from an intrusive, frightening voice that commands harmful acts; context, distress, control, associated symptoms, and impairment guide the distinction. Neither cultural membership nor an unusual experience alone proves or rules out psychosis. Ask open questions about the patient's own practice rather than assuming everyone in a group shares it. Consider language access and an appropriate interpreter when needed. A good formulation connects the patient's explanation with a careful psychiatric assessment and a treatment plan they can understand.

Worked example: A 58-year-old reports hearing a deceased mother's voice during a mourning ritual. They find it comforting, function normally, and report no disorganization, persistent voices, or fear. The PMHNP asks about the ritual, meaning, frequency, and other symptoms before deciding that this report alone does not establish psychosis. They remain alert to changes in distress or functioning on follow-up.

Watch the distinction: Automatically labeling an unfamiliar mourning experience a hallucination can misdiagnose the patient. Automatically calling every experience cultural can also miss distressing or dangerous symptoms.

Reference: [1]

57. Spiritual beliefs and existential distress

Serious illness can raise questions about meaning, identity, guilt, hope, and mortality without automatically indicating a psychiatric disorder. Ask what the patient means by statements such as “life has no point,” because existential distress, depression, and suicidal intent can overlap but require different responses. Directly assess mood symptoms, hopelessness, suicidal thoughts, intent, and ability to remain safe. Spiritual beliefs may provide comfort, conflict, or both; let the patient define their role in care. If the patient wants a spiritual adviser or community support, help incorporate that resource while respecting privacy and clinical boundaries. Treatment can also include psychotherapy that explores values and sources of meaning. A requested spiritual resource complements, rather than replaces, assessment and treatment when serious depressive symptoms or immediate risk are present.

Worked example: A 62-year-old with advanced illness asks, “Does my life still matter?” and requests a spiritual adviser. The PMHNP asks about the meaning of the question, assesses depression and suicidal thoughts directly, and finds no intent or plan. With permission, they arrange the requested adviser and discuss valued relationships and support. They continue to monitor mood because existential distress and depression may coexist.

Watch the distinction: A spiritual request is not evidence of psychosis, and an existential question is not proof of suicidal intent. Both deserve respectful exploration and direct safety assessment.

Reference: [1]

58. Sexual orientation and gender identity

Use the name and pronouns a patient gives, and ask only identity-related questions that serve care. Sexual orientation and gender identity are not diagnoses. Repeated rejection, discrimination, bullying, or fear of disclosure can increase stress and limit access to support; assess those experiences as possible contributors to symptoms rather than assuming a causal story. For an adolescent, ask about safety at school and home, trusted adults, sleep, mood, anxiety, and self-harm in developmentally appropriate language. Explain confidentiality limits and make disclosure decisions under applicable minor-consent and safety rules. Treatment should address the actual syndrome and the harmful environment, including support planning where feasible. A respectful clinical relationship can improve the accuracy of the history because the patient has less reason to conceal relevant experiences.

Worked example: A 16-year-old transgender student reports anxiety after repeated bullying. The PMHNP uses the student's stated name and pronouns, asks when anxiety occurs, assesses school safety and self-harm, and identifies one trusted adult. The care plan addresses anxiety symptoms and a feasible school support route with the adolescent's participation. Gender identity itself is not presented as the illness.

Watch the distinction: Attributing anxiety to identity overlooks bullying, safety, and other causes. Conversely, avoiding identity-related questions entirely may miss the stressors and supports that shape care.

Reference: [1]

59. Access, disability, and advocacy

Symptoms affect daily life through more than diagnosis alone. Travel, cost, scheduling, language, physical access, and cognitive or sensory needs may determine whether a patient can attend treatment or carry out a plan. Ask which task is difficult, how often, and what support would change it. For educational or workplace accommodations, describe documented functional limitations and relevant care needs with the patient's consent; the responsible institution applies its eligibility rules. Benefits processes may require separate evidence and decisions. Advocacy includes helping the patient understand options, coordinating with appropriate services, and choosing a realistic plan, without promising an outcome. Protect confidentiality by sharing only information the patient authorizes or that a valid legal process requires. Reassess whether the accommodation or support actually improves participation.

Worked example: A 20-year-old student misses morning classes because treatment appointments and symptoms disrupt attendance. With consent, the PMHNP documents the relevant functional pattern and recommends consideration of flexible attendance or scheduling. The student submits the request to the college's accommodation office, which determines eligibility. Follow-up checks whether the arrangement helps the student attend and complete work.

Watch the distinction: A diagnosis does not automatically establish a particular accommodation or benefit. Describe the functional need accurately and leave formal eligibility decisions to the responsible body.

Reference: [1]

60. Professional standards and boundaries

Professional boundaries protect patients when a service exceeds a clinician's legal authority, training, or available support. The ANCC PMHNP test content outline includes psychiatric-mental health nursing standards and scope among relevant knowledge, but an outline does not grant practice privileges. A PMHNP should identify the proposed service, check the state or territorial rules and institutional requirements that govern it, and assess personal competence. Consultation can support a decision but does not erase a legal restriction or replace needed training. If the service cannot be provided safely within scope, arrange timely referral or another appropriate pathway while addressing immediate needs. Document the clinical assessment, the boundary identified, consultation, communication with the patient, and the resulting plan. The aim is continuity and accountable care.

Worked example: A PMHNP is asked to provide a procedure for which they lack training and are unsure of state authorization. They clarify the applicable scope and credentialing requirements before agreeing to perform it. Meanwhile, they assess the patient's immediate need, explain the limit, and arrange a qualified referral or consultation. The record shows the reasoning and follow-through rather than simply noting that the request was declined.

Watch the distinction: Certification alone does not establish every state practice privilege or individual competence. Referral should be paired with assessment, communication, and a documented plan for the patient's needs.

Reference: [1]; [2]

Official references and further reading

All study guides

Scientific Foundation

1. Stress physiology and symptom persistence

2. Brain circuits behind psychiatric symptoms

3. Dopamine pathways and drug effects

4. Serotonin signaling and treatment latency

5. GABA, glutamate, and neural excitation

6. Pharmacokinetic interactions

7. Organ function and medication exposure

8. Receptor profiles and adverse effects

9. Movement and toxic syndromes

10. Heritability and pharmacogenomics

11. Neurodevelopment across childhood

12. Aging, cognition, and drug sensitivity

13. Focused physical assessment

Advanced Practice Skills

14. Opening a clinical interview

15. Motivational interviewing

16. Depression and anxiety screening

17. Multi-informant ADHD assessment

18. Mental status examination

19. Attention and fluctuating cognition

20. Suicide risk formulation

21. Violence risk assessment

22. Agitation and immediate stabilization

23. Intoxication, overdose, and withdrawal

24. Alcohol and drug screening tools

25. Withdrawal severity instruments

26. Metabolic health promotion

27. Psychoeducation that changes decisions

28. Recovery and resilience planning

29. Sleep assessment as clinical evidence

30. Safeguarding and trauma-informed assessment

Diagnosis and Treatment

31. Unipolar depression versus bipolar illness

32. Anxiety presentations and panic

33. Trauma-related diagnosis

34. Psychosis and its differentials

35. ADHD across the lifespan

36. Neurocognitive disorder and delirium

37. Substance-induced symptoms and treatment

38. Eating disorders and medical risk

39. Selecting diagnostic tests

40. Antidepressant selection and monitoring

41. Mood stabilizers and laboratory safety

42. Antipsychotic selection and monitoring

43. Somatic and complementary treatments

Psychotherapy and Related Theories

44. Cognitive behavioral therapy

45. Dialectical behavior therapy

46. Interpersonal therapy

47. Exposure and behavioral learning

48. Humanistic practice and the alliance

49. Models of change

50. Developmental and family theories

Ethics, Legal Principles, and Cultural Care

51. Informed consent and capacity

52. Confidentiality and releases

53. Threats, protection, and disclosure

54. Involuntary care and least restriction

55. Children, assent, and guardians

56. Cultural formulation

57. Spiritual beliefs and existential distress

58. Sexual orientation and gender identity

59. Access, disability, and advocacy

60. Professional standards and boundaries

Official references and further reading

Frequently Asked Questions

Related Study Guides

Certified Pediatric Nurse Practitioner - Acute Care (CPNP-AC)

Women's Health Care Nurse Practitioner (WHNP-BC)

Adult-Gerontology Acute Care Nurse Practitioner (AGACNP-BC)